Q32 Bio Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Q32 Bio Inc. (QTTB), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are QTTB insiders buying or selling?
Q32 Bio Inc. insiders reported 4 open-market buys ($42.1M) and 81 sells ($109.9M) across 85 Form 4 filings — a net selling position of $67.8M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 2, 2026)
Insider sentiment
Net sellingNet insider flow of $67.8M in net selling. 2 insider buys in the last 90 days.
Recent QTTB insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | Diyong Xu | Director, 10% Owner | Purchase | 1.9M | $8.00 | $15.0M |
| Jun 2, 2026 | ORBIMED ADVISORS LLC | Director, 10% Owner | Purchase | 1.9M | $8.00 | $15.0M |
| Feb 28, 2026 | Lee Kalowski | CFO and President | Sale | 4.0K | $4.51 | $18.0K |
| Feb 28, 2026 | Jodie Pope Morrison | CEO | Sale | 9.9K | $4.51 | $44.7K |
| Feb 28, 2026 | Shelia M. Violette | Chief Scientific Officer | Sale | 2.8K | $4.51 | $12.7K |
| Dec 5, 2025 | Jodie Pope Morrison | CEO | Sale | 22.5K | $3.46 | $77.9K |
| Dec 5, 2025 | Lee Kalowski | CFO and President | Sale | 9.1K | $3.46 | $31.4K |
| Aug 28, 2025 | Jodie Pope Morrison | CEO | Sale | 10.5K | $1.80 | $18.9K |
| Aug 28, 2025 | Shelia M. Violette | Chief Scientific Officer | Sale | 3.0K | $1.80 | $5.4K |
| Aug 28, 2025 | Lee Kalowski | CFO and President | Sale | 4.2K | $1.80 | $7.6K |
| Aug 14, 2024 | Arthur Tzianabos | Director | Sale | 265 | $24.20 | $6.4K |
| Apr 23, 2024 | Paul Alloway | Former President and Chief Operating Officer of Homology Medicines, Inc. | Sale | 268 | $24.21 | $6.5K |
| Apr 23, 2024 | Charles Michaud Jr | Former Vice President, Corporate Controller and Treasurer of Homology Medicines, Inc. | Sale | 75 | $24.20 | $1.8K |
| Feb 15, 2024 | Arthur Tzianabos | Director | Sale | 13.0K | $0.57 | $7.4K |
| Jan 5, 2024 | Paul Alloway | President and Chief Operating Officer | Sale | 7.3K | $0.57 | $4.1K |
| Jan 5, 2024 | Charles Michaud Jr | Vice President, Corporate Controller and Treasurer | Sale | 1.7K | $0.57 | $975.27 |
| Sep 8, 2023 | Albert Seymour | President and Chief Executive Officer | Sale | 1.4K | $1.15 | $1.7K |
| Aug 8, 2023 | Julie Jordan | Chief Medical Officer | Sale | 1.9K | $1.39 | $2.6K |
| Aug 4, 2023 | Julie Jordan | Chief Medical Officer | Sale | 99 | $1.31 | $129.69 |
| Mar 6, 2023 | Paul Alloway | Chief Legal Officer and Secretary | Sale | 11.0K | $1.45 | $15.9K |
| Jan 11, 2023 | Michael Lee Blum | Chief Commercial Officer | Sale | 2.5K | $1.39 | $3.4K |
| Jan 11, 2023 | Paul Alloway | Chief Legal Officer and Secretary | Sale | 3.1K | $1.39 | $4.3K |
| Jan 11, 2023 | Bradford W Smith | Chief Financial and Business Officer and Treasurer | Sale | 3.7K | $1.39 | $5.2K |
| Jan 11, 2023 | Albert Seymour | President and Chief Executive Officer | Sale | 3.6K | $1.39 | $5.0K |
| Jan 11, 2023 | Arthur Tzianabos | Director | Sale | 10.6K | $1.39 | $14.8K |
Showing the 25 most recent of 85 Form 4 filings for Q32 Bio Inc..
Most active QTTB insiders
- Albert Seymour12 filings
- Arthur Tzianabos12 filings
- Bradford W Smith11 filings
- Timothy P Kelly11 filings
- 5AM Ventures IV, L.P.6 filings
Ask anything about QTTB insider activity
Use Trabud's AI agent to query Q32 Bio Inc.'s Form 4 history in plain English — "Show me QTTB CEO purchases this year" or compare it against any other ticker.
Open the AI agentQTTB insider trading FAQ
Are Q32 Bio Inc. insiders buying or selling?
Across 85 SEC Form 4 filings, Q32 Bio Inc. (QTTB) insiders reported 4 open-market purchases totaling $42.1M and 81 sales totaling $109.9M. That is a net selling position of $67.8M.
How many insiders trade QTTB stock?
18 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Q32 Bio Inc.. The most recent filing was accepted on Jun 2, 2026.
Where does Trabud get QTTB insider trading data?
All QTTB insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.